Myrtle S Potter is Director of Guardant Health, Inc.. Currently has a direct ownership of 13,790 shares of GH, which is worth approximately $650,888. The most recent transaction as insider was on Feb 15, 2023, when has been sold 69 shares (Restricted Stock Units) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.8K
1.51% 3M change
86.93% 12M change
Total Value Held $650,888

MYRTLE S POTTER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2023
BUY
Grant, award, or other acquisition
-
69 Added 5.93%
1,094 Restricted Stock Units
Jan 15 2023
BUY
Exercise of conversion of derivative security
-
68 Added 6.22%
1,025 Restricted Stock Units
Dec 15 2022
BUY
Grant, award, or other acquisition
-
68 Added 6.63%
957 Restricted Stock Units
Nov 15 2022
BUY
Exercise of conversion of derivative security
-
69 Added 7.2%
889 Restricted Stock Units
Oct 15 2022
BUY
Exercise of conversion of derivative security
-
820 Added 50.0%
820 Restricted Stock Units

Also insider at

RAD
RITE AID CORP Healthcare
UROV
Urovant Sciences Ltd.
MYOV
Myovant Sciences Ltd. Healthcare
DNA
Ginkgo Bioworks Holdings, Inc. Healthcare
MSP

Myrtle S Potter

Director
Camp Hill, PA

Track Institutional and Insider Activities on GH

Follow Guardant Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

News

Receive news related to Guardant Health, Inc.

Track Activities on GH